Showing results (271-280 of 408) with videos related to

Sort By:
Pageof 41
Neurology|December 17, 2020
Siponimod and Cognition in Secondary Progressive Multiple Sclerosis: EXPAND Secondary AnalysesRalph H B Benedict, Davorka Tomic, Bruce A Cree, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 1, 2021
Q waves are the strongest electrocardiographic variable associated with primary prophylactic implantable cardioverter-defibrillator benefit: a prospective multicentre studyAri Pelli, M Juhani Junttila, Tuomas V Kenttä, et al.
Age and Ageing|September 2, 2021
Reduced Clostridioides difficile infections in hospitalised older people through multiple quality improvement strategiesCarla Maria Dohrendorf, Steffen Unkel, Simone Scheithauer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 9, 2024
Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in paediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT AlportOliver Gross, Jan Boeckhaus, Lutz T Weber, et al.
Journal of the American Heart Association|May 28, 2024
Lack of Prognostic Value of T-Wave Alternans for Implantable Cardioverter-Defibrillator Benefit in Primary PreventionAri Pelli, Tuomas V Kenttä, M Juhani Junttila, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 8, 2019
Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational studyMichael Oellerich, Maria Shipkova, Thomas Asendorf, et al.
International Journal of Cardiology|March 20, 2020
Electrocardiogram as a predictor of survival without appropriate shocks in primary prophylactic ICD patients: A retrospective multi-center studyAri Pelli, Tuomas V Kenttä, M Juhani Junttila, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 15, 2022
A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer ImmunotherapiesStephen Palmer, Isabelle Borget, Tim Friede, et al.
Trials|June 30, 2021
Survival analysis for AdVerse events with VarYing follow-up times (SAVVY)-estimation of adverse event risksRegina Stegherr, Claudia Schmoor, Jan Beyersmann, et al.
European Journal of Heart Failure|July 18, 2024
Catheter-based ablation to improve outcomes in patients with atrial fibrillation and heart failure with preserved ejection fraction: Rationale and design of the CABA-HFPEF-DZHK27 trialAbdul S Parwani, Stefan Kääb, Tim Friede, et al.
Pageof 41